SEC FORM 4
$98,479.12
Mineralys Therapeutics, Inc. (MLYS)
Acquisition (code M) of 7,438 shares at $13.24 per share.
Reporting Person Warren Eric · Officer Title Chief Commercial Officer · Transaction Code M
Traded Sep 21, 2026 · Disclosed Sep 22, 2026
Source: SEC Form 4 · 0001916048-26-000014 · filed 2026-09-22 · View filing →